|
|
Blood, Vol. 111, Issue 1, 379-382, January 1, 2008
Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways
Blood Tamburini et al.
111: 379
Supplemental materials: for Tamburini et al
Files in this Data Supplement:
|
|
